NCT03476018

Trial to Optimally Show the Pharmacological Action of Z-100

Z-100 Pharmacological Trial: A Randomised Placebo-controlled Trial of Z-100 Plus Radiation Therapy in Subjects With Locally Advanced Cervical Cancer

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 72 (actual)
• Sponsor: Zeria Pharmaceutical · Industry
• Sex: Female
• Age: 21 Years – 79 Years
• Healthy volunteers: Not accepted

Summary

The objective of this clinical trial is to evaluate the change of the immunological parameter levels in FIGO stage IIIB cervical cancer subjects by administration of Z-100

Conditions

• Cervical Cancer

Interventions

Type	Name	Description
DRUG	Z-100	Twice a week until 29 days after completion of chemoradiotherapy, then once every 14 days
DRUG	Placebos	Twice a week until 29 days after completion of chemoradiotherapy, then once every 14 days

Timeline

• Start date: 2018-04-02
• Primary completion: 2021-07-20
• Completion: 2021-12-10
• First posted: 2018-03-23
• Last updated: 2022-06-16

Locations

2 sites across 1 country: Vietnam